480 related articles for article (PubMed ID: 35323449)
1. Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence.
Flores-Contreras EA; González-González RB; Rodríguez-Sánchez IP; Yee-de León JF; Iqbal HMN; González-González E
Biosensors (Basel); 2022 Mar; 12(3):. PubMed ID: 35323449
[TBL] [Abstract][Full Text] [Related]
2. Rapid diagnosis of SARS-CoV-2 using potential point-of-care electrochemical immunosensor: Toward the future prospects.
Ranjan P; Singhal A; Yadav S; Kumar N; Murali S; Sanghi SK; Khan R
Int Rev Immunol; 2021; 40(1-2):126-142. PubMed ID: 33448909
[TBL] [Abstract][Full Text] [Related]
3. The potential application of electrochemical biosensors in the COVID-19 pandemic: A perspective on the rapid diagnostics of SARS-CoV-2.
Mahshid SS; Flynn SE; Mahshid S
Biosens Bioelectron; 2021 Mar; 176():112905. PubMed ID: 33358285
[TBL] [Abstract][Full Text] [Related]
4. Paper-Based Biosensors: Frontiers in Point-of-Care Detection of COVID-19 Disease.
Antiochia R
Biosensors (Basel); 2021 Apr; 11(4):. PubMed ID: 33917183
[TBL] [Abstract][Full Text] [Related]
5. The role of the surface ligand on the performance of electrochemical SARS-CoV-2 antigen biosensors.
Szunerits S; Pagneux Q; Swaidan A; Mishyn V; Roussel A; Cambillau C; Devos D; Engelmann I; Alidjinou EK; Happy H; Boukherroub R
Anal Bioanal Chem; 2022 Jan; 414(1):103-113. PubMed ID: 33616686
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances in Molecular and Immunological Diagnostic Platform for Virus Detection: A Review.
Trinh KTL; Do HDK; Lee NY
Biosensors (Basel); 2023 Apr; 13(4):. PubMed ID: 37185566
[TBL] [Abstract][Full Text] [Related]
7. Instrument-free, CRISPR-based diagnostics of SARS-CoV-2 using self-contained microfluidic system.
Li Z; Ding X; Yin K; Avery L; Ballesteros E; Liu C
Biosens Bioelectron; 2022 Mar; 199():113865. PubMed ID: 34906838
[TBL] [Abstract][Full Text] [Related]
8. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
[TBL] [Abstract][Full Text] [Related]
9. Molecular Diagnostic Tools for the Detection of SARS-CoV-2.
Datta M; Singh DD; Naqvi AR
Int Rev Immunol; 2021; 40(1-2):143-156. PubMed ID: 33439059
[TBL] [Abstract][Full Text] [Related]
10. The seroprevalence of SARS-CoV-2 in a rural southwest community.
Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
[TBL] [Abstract][Full Text] [Related]
11. Clinical Utility of Biosensing Platforms for Confirmation of SARS-CoV-2 Infection.
Phan LMT; Tieu MV; Pham TT; Cho S
Biosensors (Basel); 2021 May; 11(6):. PubMed ID: 34073756
[TBL] [Abstract][Full Text] [Related]
12. A rapid diagnosis of SARS-CoV-2 using DNA hydrogel formation on microfluidic pores.
Kim HS; Abbas N; Shin S
Biosens Bioelectron; 2021 Apr; 177():113005. PubMed ID: 33486135
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-based detection of SARS-CoV-2: A review from sample to result.
Nouri R; Tang Z; Dong M; Liu T; Kshirsagar A; Guan W
Biosens Bioelectron; 2021 Apr; 178():113012. PubMed ID: 33497879
[TBL] [Abstract][Full Text] [Related]
14. Lab-on-a-Disc for Point-of-Care Infection Diagnostics.
Sunkara V; Kumar S; Sabaté Del Río J; Kim I; Cho YK
Acc Chem Res; 2021 Oct; 54(19):3643-3655. PubMed ID: 34516092
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the role of nanostructured materials in the point-of-care diagnostics for COVID-19: a comprehensive review.
Krishnan S; Dusane A; Morajkar R; Venkat A; Vernekar AA
J Mater Chem B; 2021 Aug; 9(30):5967-5981. PubMed ID: 34254626
[TBL] [Abstract][Full Text] [Related]
16. Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection.
Elledge SK; Zhou XX; Byrnes JR; Martinko AJ; Lui I; Pance K; Lim SA; Glasgow JE; Glasgow AA; Turcios K; Iyer NS; Torres L; Peluso MJ; Henrich TJ; Wang TT; Tato CM; Leung KK; Greenhouse B; Wells JA
Nat Biotechnol; 2021 Aug; 39(8):928-935. PubMed ID: 33767397
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of three point-of-care lateral flow immunoassays for detection of anti-SARS-CoV-2 antibodies: data from 100 healthcare workers in Brazil.
Conte DD; Carvalho JMA; de Souza Luna LK; Faíco-Filho KS; Perosa AH; Bellei N
Braz J Microbiol; 2021 Sep; 52(3):1161-1165. PubMed ID: 33871824
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19.
Vatankhah M; Azizi A; Sanajouyan Langeroudi A; Ataei Azimi S; Khorsand I; Kerachian MA; Motaei J
Crit Rev Clin Lab Sci; 2021 Jun; 58(4):225-241. PubMed ID: 33245685
[TBL] [Abstract][Full Text] [Related]
19. Utilizing Electrochemical-Based Sensing Approaches for the Detection of SARS-CoV-2 in Clinical Samples: A Review.
Zambry NS; Obande GA; Khalid MF; Bustami Y; Hamzah HH; Awang MS; Aziah I; Manaf AA
Biosensors (Basel); 2022 Jun; 12(7):. PubMed ID: 35884276
[TBL] [Abstract][Full Text] [Related]
20. Remote Fingerstick Blood Collection for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Testing.
Garcia-Beltran WF; Miller TE; Kirkpatrick G; Nixon A; Astudillo MG; Yang D; Mahanta LM; Murali M; Dighe AS; Lennerz J; Thierauf J; Naranbhai V; Iafrate AJ
Arch Pathol Lab Med; 2021 Apr; 145(4):415-418. PubMed ID: 33264390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
